The 10 Most Exciting Drugs in the 2019 Pipeline
Approved and upcoming drugs to look forward to this year.
Dacomitinib Approved for Non-Small Cell Lung Cancer
Approved by the FDA in September, this new drug serves as a first-line therapy for patients with particular metastatic non-small lung cancer.
The Smart Technology That Will Change Diabetes Care
GPS-based dietary prompts, continuous glucose monitors among the devices poised to revolutionize diabetes treatment and patient management.
Vaccine to Prevent Recurring Strokes Shows Early Promise
Research in mice has found that a vaccine may be able to help prevent the recurrence of strokes.
Andexxa for Reversal of Factor Xa Inhibitors
The 28 Latest Drug Approvals
What you need to know about the FDA’s most recent novel drug approvals.
What Pharmacists Need to Know About Lofexidine
FDA approves lofexidine for opioid withdrawal symptoms.
What Pharmacists Need to Know About Epidiolex
The FDA recently approved cannabidiol oral solution to treat seizures.
What Pharmacists Need to Know About Erenumab-aooe
The latest New Drug Review covers Amgen’s migraine medication.
FDA Approves First Fast-Track Generic
The drug is the first approved under the agency's new, quicker generic approval designation.
Avatrombopag for Thrombocytopenia in Adults
Our latest New Drug Review covers Dova’s most recent medication.
The 10 Latest Novel Drug Approvals
A roundup of the 10 most recent FDA-approved medications.
Betrixaban for Prophylaxis of Venous Thromboembolism
Betrixaban has been approved by the FDA for patients at risk for thromboembolisms.
First Nonopioid Drug Approved for Opioid Drug Withdrawal
What you need to know about the latest FDA approval.
Ibalizumab-uiyk (Trogarzo) for Multi-Drug-Resistant HIV-1
What pharmacists need to know about the new antibody approved for multi-drug-resistant HIV-1.
Apalutimide for Prostate Cancer: What to Know
FDA approves apalutamide for castration-resistant prostate cancer.
First in Class Drug for Glaucoma: What Pharmacists Need to Know
Netarsudil opthalmis solution (Rhopressa, Aerie Pharmaceuticals), is approved by the FDA for treatment of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Meropenem/Vaborbactam for Complicated UTIs
Vabomere combines a carbapenem and a beta-lactamase inhibitor as a treatment for complicated urinary tract infections.
FDA Approves Emicizumab-kxwh for Hemophilia A
Emicizumab-kxwh brings together factors IXa and X to restore the function of the missing activated factor VIII and the blood clotting process.
Delafloxacin (Baxdela) for Acute Bacterial Skin Infections
Delafloxacin (Baxdela) for treatment of acute bacterial skin and skin structure infections including cellulitis, wound infection, major cutaneous abscess, and burn infection.
First Drug with an Ingestible Sensor Approved
Abilify MyCite is the first drug to contain a bit of technology that reports that it has been taken as prescribed.
Edaravone (Radicava) for ALS
Edaravone has been approved for patients with amyotropic lateral sclerosis.
Ocrelizumab for Multiple Sclerosis
The FDA has approved ocrelizumab for treating relapsing forms of multiple sclerosis and primary progressive multiple sclerosis.
New Drug Review: Sarilumab
The FDA approved Kevzara for RA patients.
Surescripts Expands Medication History Service
More information could help save lives.
Omnicell System Streamlines Medication Management
New technology is helping patients, nurses, and pharmacists alike.
New Product Uses Dual Approach to Dissolve Cerumen
New product uses new technology to break down earwax
New Drug Review
Plecanatide: Approved for Chronic Idiopathic Constipation
Sugammadex: The First Selective Relaxant Binding Agent
Sugammadex reverses vecuronium and rocuronium, two drugs used to facilitate endotracheal intubation in surgery.
A product for every hair-care need
Americans spend billions of dollars on products to address specific hair and scalp concerns each year-whether that be color, condition, or appearance.
